Xuli Meng
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Nab-paclitaxel Compared With Docetaxel in the Neoadjuvant Chemotherapy Breast Cancer (NCT05251766) | Xuli Meng | 2022-04-20 |
Track Xuli Meng automatically
Every clearance here is in the API, with alerts when new ones post.